This low frequency of concurrent mutations suggests that the biological effects of IDH1 and IDH2 are similar, and this idea is corroborated by the similar impact of these mutations on the distribution of cytosine methylation and the global DNA methylation profile in AML cells (Figueroa et al., 2010). This evidence concerns the gene IDH1 and acute myeloid leukemia.